Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Gefitinib Tablets

Approval Number

国药准字H20203215

Company江苏恒瑞医药股份有限公司

Registration Date

May 26, 2020

Drug Information

Generic Name

吉非替尼片

Brand Name

艾兴康

Dosage Form

片剂

Strength

0.25g

Drug Type

化学药品

Registration Date

May 26, 2020

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号、连云港经济技术开发区临港产业区东晋路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

吉非替尼片 - NMPA 批准文号 | MedPath